Sort   by:  
 Page size 
UnknownBenefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
Not available
S-EPMC9208859 | biostudies-literature
UnknownEffect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Not available
S-EPMC7298607 | biostudies-literature
UnknownPredictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control System.
Not available
S-EPMC8252894 | biostudies-literature
UnknownA Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
Not available
S-EPMC7920146 | biostudies-literature
UnknownHealth-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control.
Not available
S-EPMC8215424 | biostudies-literature
UnknownTwelve-month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes.
Not available
S-EPMC10524740 | biostudies-literature
UnknownAdditive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.
Not available
S-EPMC12635876 | biostudies-literature
Sort   by:  
 Page size